Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Brochures & Literature

 

 

View Channel

 

Conferences | Events

New Application Note from YMC - Fast and easy achiral and chiral analysis of cannabinoids

publication date: Aug 24, 2020
 | 
author/source: YMC Europe GmbH

new-application-note-from-ymc-fast-and-easy-achiral-and


(U)HPLC analysis of original composition of cannabis plant material is necessary for such purposes as phenotype determination and quality control of medical cannabis used for therapeutic treatment.

For fast and secure results YMC developed robust (U)HPLC methods for RP and chiral LC. Also, challenging distinction between cannabigerol (CBG) andcannabidiol (CBD) are easily achieved. A solution for the chiral separation of tetrahydrocannabinol (THC) isomers using YMC’s polysaccharide phase CHIRAL ART Amylose-C completes the set nicely.

It has been repeatedly suggested that the effect of Δ9-Tetrahydrocannabinol (THC) or other single cannabinoids are not equal to that of whole cannabis preparations: some of the bio-activity observed for these preparations could be due to acidic cannabinoids. That is why a method which separates both neutral compounds such as THC as well as acidic cannabi-noids such as THCA in plant material must be available. In Europe there is a growing interest in medicinal can-nabis, which is used to treat a series of pathologies. Nonetheless, cannabis is a strictly controlled drug under specific regulations or is illegal even for thera-peutic purposes in many European countries. Certified medicinal cannabis is currently used for the treatment of a number of pathologies, including multiple sclerosis, epilepsy, neuropathic pain, arthritis, depression, anx-iety disorders, sleep disorders, psychosis, glaucoma and Tourette’s syndrome. It is also used for the relief of symptoms such as nausea and vomiting as a result of chemotherapy, and appetite stimulation in patients suffering from HIV and AIDS.

The cannabinoids form a group of related compounds of which about 70 are known. Among the major cannab-inoids in Cannabis sativa L. THC is generally accepted to be the compound that possesses the psychoactive properties.

Download your copy of the application note with all method details! or visit our homepage to find out more about YMC-Triart, YMC’s Meteoric Core or YMC’s CHIRAL ART columns.

 

Click here to learn more

more news from YMC


 


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners